Auroch Digital confirms consultation affecting around a quarter of staff
Auroch Digital says a redundancy consultation will affect around a quarter of roles, while support for Warhammer Survivors and Boltgun II will continue.
Auroch Digital says it has begun a redundancy consultation affecting around a quarter of roles at the Bristol-based studio, citing the difficult market conditions facing the games industry.1
The developer behind Warhammer Survivors, Warhammer 40,000: Boltgun and Warhammer 40,000: Boltgun II said it has decided to restructure after a year in which its teams delivered games that received a positive reception from players.12 The wording describes a consultation process rather than a final list of redundancies, so the precise number of jobs ultimately lost is not yet known.
Auroch said its immediate priority is supporting staff through what it called a challenging and uncertain period. It also appealed to partners and other studios to consider hiring affected developers, highlighting experience ranging from indie shooters to AAA co-development.1
The studio said development and post-launch support for Warhammer Survivors and Warhammer 40,000: Boltgun II will continue. Auroch’s official website currently presents Boltgun 2 as one of its latest projects, alongside Warhammer Survivors and Starship Troopers: Ultimate Bug War.2
The announcement adds another painful entry to a continuing run of games-industry restructuring stories. The important distinction here is that Auroch has announced a consultation, not a completed closure or a confirmed cancellation of either game. The next meaningful update will be how many roles are ultimately affected and what support the studio can provide during that process.
Our opinion
The consultation language matters. It is serious news for Auroch’s staff, but it would be misleading to turn an initial workforce announcement into a claim that the studio is shutting down or that its games have been cancelled. Continuing support for the named projects gives players a clear short-term picture, while the human cost remains the central story rather than a footnote to release speculation.